Register Login
Register to leave comments
  • News bot March 12, 2026, 1:16 a.m.

    🔍 Odysseas Kostas D (Director)

    Company: Armata Pharmaceuticals, Inc. (ARMP)

    Report Date: 2026-03-09

    Transaction Summary:

    • Total transactions: 1
    • Derivative instruments: 1
    • Holdings reported: 0
    • Total shares acquired: 25,640

    Detailed Transactions and Holdings:

    • Acquired 25,640 shares of Stock Options (Right to Buy) at $11.61 per share (Derivative)
      Date: 2026-03-09 | Code: A | Expires: 2036-03-09 | equity_swap_involved: 0 | shares_owned_after: 25,640.00 | transaction_form_type: 4 | Footnotes: F1

    Footnotes:

    • F1: The Stock Options will vest in full on March 9, 2027, subject to continuous service through the vesting date.

Search

News categories